231 related articles for article (PubMed ID: 35372404)
1. Dawn of Precision Medicine in Psoriatic Arthritis.
Miyagawa I; Tanaka Y
Front Med (Lausanne); 2022; 9():851892. PubMed ID: 35372404
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases
Tanaka Y; Kubo S; Miyagawa I; Iwata S; Nakayamada S
Semin Arthritis Rheum; 2019 Jun; 48(6):1146-1150. PubMed ID: 31079846
[TBL] [Abstract][Full Text] [Related]
3. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
4. Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis.
Miyagawa I; Tanaka Y
Expert Rev Clin Immunol; 2020 Feb; 16(2):199-206. PubMed ID: 31905298
[No Abstract] [Full Text] [Related]
5. Optimal Biologic Selection for Treatment of Psoriatic Arthritis: the Approach to Precision Medicine.
Miyagawa I; Nakayamada S; Tanaka Y
Curr Rheumatol Rep; 2019 Mar; 21(5):21. PubMed ID: 30891646
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Miyagawa I; Nakayamada S; Ueno M; Miyazaki Y; Ohkubo N; Inoue Y; Kubo S; Tanaka Y
Front Med (Lausanne); 2022; 9():934937. PubMed ID: 35966881
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
[TBL] [Abstract][Full Text] [Related]
8. Precision medicine in autoimmune diseases: fact or fiction.
Toro-Domínguez D; Alarcón-Riquelme ME
Rheumatology (Oxford); 2021 Sep; 60(9):3977-3985. PubMed ID: 34003926
[TBL] [Abstract][Full Text] [Related]
9. Serum procalcitonin in systemic autoimmune diseases--where are we now?
Buhaescu I; Yood RA; Izzedine H
Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic Arthritis: Newer and Older Therapies.
Chao R; Kavanaugh A
Curr Rheumatol Rep; 2019 Dec; 21(12):75. PubMed ID: 31865449
[TBL] [Abstract][Full Text] [Related]
11. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.
Giacomelli R; Afeltra A; Bartoloni E; Berardicurti O; Bombardieri M; Bortoluzzi A; Carubbi F; Caso F; Cervera R; Ciccia F; Cipriani P; Coloma-Bazán E; Conti F; Costa L; D'Angelo S; Distler O; Feist E; Foulquier N; Gabini M; Gerber V; Gerli R; Grembiale RD; Guggino G; Hoxha A; Iagnocco A; Jordan S; Kahaleh B; Lauper K; Liakouli V; Lubrano E; Margiotta D; Naty S; Navarini L; Perosa F; Perricone C; Perricone R; Prete M; Pers JO; Pitzalis C; Priori R; Rivellese F; Ruffatti A; Ruscitti P; Scarpa R; Shoenfeld Y; Triolo G; Tzioufas A
Autoimmun Rev; 2021 Feb; 20(2):102738. PubMed ID: 33326854
[TBL] [Abstract][Full Text] [Related]
12. Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus.
Nagafuchi Y; Shoda H; Fujio K
Cells; 2019 Feb; 8(2):. PubMed ID: 30744169
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine in psoriatic arthritis: how should we select targeted therapies?
Al-Mossawi H; Taams LS; Goodyear CS; Kirkham BW; McInnes IB; Siebert S; Coates LC
Lancet Rheumatol; 2019 Sep; 1(1):e66-e73. PubMed ID: 38229362
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
15. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease.
Chimenti MS; Caso F; Alivernini S; De Martino E; Costa L; Tolusso B; Triggianese P; Conigliaro P; Gremese E; Scarpa R; Perricone R
Autoimmun Rev; 2019 Jun; 18(6):565-575. PubMed ID: 30959209
[TBL] [Abstract][Full Text] [Related]
16. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
17. [Prolactin as an immunomodulatory factor in psoriatic arthritis].
Kokot I; Pawlik-Sobecka L; Płaczkowska S; Piwowar A
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1265-72. PubMed ID: 24379267
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease.
Arvikar SL; Crowley JT; Sulka KB; Steere AC
Arthritis Rheumatol; 2017 Jan; 69(1):194-202. PubMed ID: 27636905
[TBL] [Abstract][Full Text] [Related]
19. Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?
Vastarella M; Megna M; Lupoli GA; Napolitano M; Gallo L; Balato A; Tasso M; Costa L; Fabbrocini G; Peluso R
Australas J Dermatol; 2021 May; 62(2):e207-e211. PubMed ID: 33070319
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of psoriatic arthritis.
Stober C
Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101694. PubMed ID: 34108102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
